Alkeon Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Hold |
2,342,373
| – | – | ﹤0.01% | 81 |
|
|
2025
Q1 | $2.55M | Sell |
2,342,373
-1,358
| -0.1% | -$1.48K | 0.01% | 80 |
|
|
2024
Q4 | $3.54M | Hold |
2,343,731
| – | – | 0.01% | 72 |
|
|
2024
Q3 | $3.49M | Sell |
2,343,731
-1,630
| -0.1% | -$2.43K | 0.01% | 75 |
|
|
2024
Q2 | $3.8M | Hold |
2,345,361
| – | – | 0.01% | 76 |
|
|
2024
Q1 | $3.99M | Hold |
2,345,361
| – | – | 0.01% | 73 |
|
|
2023
Q4 | $7.27M | Sell |
2,345,361
-2,053
| -0.1% | -$6.36K | 0.02% | 72 |
|
|
2023
Q3 | $14.4M | Buy |
2,347,414
+867,547
| +59% | +$5.33M | 0.03% | 71 |
|
|
2023
Q2 | $9.26M | Buy |
1,479,867
+98,538
| +7% | +$617K | 0.02% | 83 |
|
|
2023
Q1 | $6.59M | Sell |
1,381,329
-3,938
| -0.3% | -$18.8K | 0.01% | 91 |
|
|
2022
Q4 | $12.1M | Sell |
1,385,267
-131,979
| -9% | -$1.15M | 0.05% | 87 |
|
|
2022
Q3 | $18.1M | Sell |
1,517,246
-2,689
| -0.2% | -$32K | 0.06% | 88 |
|
|
2022
Q2 | $21.7M | Sell |
1,519,935
-79,618
| -5% | -$1.13M | 0.06% | 85 |
|
|
2022
Q1 | $33.3M | Hold |
1,599,553
| – | – | 0.07% | 89 |
|
|
2021
Q4 | $36.9M | Buy |
1,599,553
+180,000
| +13% | +$4.16M | 0.07% | 96 |
|
|
2021
Q3 | $42.3M | Buy |
1,419,553
+292,135
| +26% | +$8.71M | 0.07% | 100 |
|
|
2021
Q2 | $38.5M | Sell |
1,127,418
-2,263
| -0.2% | -$77.3K | 0.06% | 94 |
|
|
2021
Q1 | $37.2M | Buy |
1,129,681
+2,530
| +0.2% | +$83.2K | 0.06% | 93 |
|
|
2020
Q4 | $69.3M | Buy |
1,127,151
+652,151
| +137% | +$40.1M | 0.11% | 83 |
|
|
2020
Q3 | $16.9M | Buy |
+475,000
| New | +$16.9M | 0.03% | 103 |
|